NEW HAVEN, Conn., Feb. 10, 2020 /PRNewswire/ — Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) today reported negative topline results from its Phase 3 clinical trial evaluating troriluzole compared to placebo for the treatment of patients with...
Next major milestone in Mino-Lok trial is the 75% interim analysis for superior efficacy and is expected in first half of 2020 CRANFORD, N.J., Feb. 4, 2020 /PRNewswire/ — Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (NASDAQ:...
Phoenix, Arizona–(Newsfile Corp. – February 5, 2020) – The Stock Day Podcast welcomed EastGate Biotech (OTC Pink: ETBI) (“the Company”), a company that focuses on innovative technological developments and produces and distributes...
Santa Ana, CA — (SBWIRE) — 02/05/2020 — Millions of researches are conducted nowadays to discover new treatments for a variety of mental disorders such as depression, Alzheimer’s disease etc. Considered as key research tools, clinical trials...
The first patient has been implanted in an investigational clinical study of STAAR Surgical’s EVO ICL family of lenses, according to a press release. EVO Visian IOLs are designed to treat a wide range of refractive error, including myopia, the release said. The...
OCALA, FL / ACCESSWIRE / February 5, 2020 / AIM ImmunoTech Inc. (NYSE American: AIM), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, today announced posting by the University of Pittsburgh Medical...
Email
Text